We recently observed that EIF4G1 is overexpressed/amplified in the majority of patients with castration-resistant prostate cancer (CRPC), and plays an essential role in prostate cancer progression, cell growth and metastasis [23]. Here, EIF4G1 is linked to prostate carcinoma.